Contiguous Stage II Marginal Zone Lymphoma Completed Phase 2 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0029471 (Contiguous Stage II Marginal Zone Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01789255Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesSupportive Care
NCT00489203Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerSupportive Care